Chemed Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +55.5% | -21.1% | +20.0% | +76.7% | +4.9% | +62.4% | -36.9% | +0.4% | +6.6% | +26.4% | -7.0% | |
| – | +1.3% | +3.4% | +2.8% | +9.1% | +16.3% | +25.2% | +4.4% | +0.2% | +2.9% | +3.6% | +2.8% | |
| – | -74.4% | -29.9% | -33.6% | -63.8% | +5,192.4% | +13.5% | +17.2% | -100.0% | – | +6.5% | -84.7% | |
| – | -13.2% | -27.0% | +179.6% | -40.4% | +5.2% | +23.8% | -76.7% | +357.1% | – | – | – | |
| – | – | -625.3% | – | – | -55.8% | +486.0% | -160.3% | – | – | – | +191.5% | |
| – | +1.3% | -9.9% | +61.7% | -17.8% | +0.3% | +11.0% | -0.3% | -2.3% | -0.8% | -12.9% | +26.8% | |
| – | +15.6% | -20.8% | +69.6% | +55.6% | +81.3% | -67.7% | -6.2% | +2.8% | +2.1% | +137.3% | -58.8% | |
| – | +9.5% | +5.3% | +5.7% | +7.4% | +6.0% | +6.5% | +4.4% | +0.0% | +6.7% | +15.3% | +17.0% | |
| – | -46.1% | +72.5% | -7.5% | +67.9% | -41.7% | +89.6% | +228.1% | -80.1% | -40.9% | +433.8% | +19.4% | |
| – | +87.3% | – | -105.1% | +1,615.6% | -78.6% | +3,093.1% | – | -150.5% | -17.7% | -80.7% | – | |
| – | -12.0% | -21.3% | +4.3% | +90.0% | -42.0% | +148.4% | +40.3% | -45.0% | -61.9% | +350.0% | +20.5% | |
| – | – | -2.0% | -818.5% | – | – | +11,694.8% | -182.9% | – | +360.4% | -145.1% | – | |
| – | +90.9% | -24.9% | +2.7% | +138.6% | +6.0% | +73.4% | -41.9% | +1.1% | +8.3% | +34.6% | -11.5% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.